This Cochrane Clinical Answer compares early versus late initiation of disease-modifying drugs after a first clinical attack suggestive of multiple sclerosis.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.